Literature DB >> 8445338

Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level.

I Gouni1, K Oka, J Etienne, L Chan.   

Abstract

Previous studies have demonstrated that endotoxin/lipopolysaccharide treatment causes a decrease in adipose tissue and heart lipoprotein lipase (LPL) activities in rats, producing hypertriglyceridemia in these animals. To examine the mechanisms for this effect of endotoxin, we studied the effects of endotoxin administration on LPL mRNA, and LPL synthetic rates and activity in rat adipose tissue and heart. Endotoxin treatment (i.p., 3 mg/100 g body weight or higher doses) produced a pronounced increase in serum triglycerides associated with a 65% decrease in adipose tissue and heart LPL activities within 7 h. Fast protein liquid chromatography (FPLC), used to separate lipoproteins in rat serum, showed that the increase in triglyceride was all in the very low density lipoprotein fraction which was accompanied by a concomitant decrease in high density lipoprotein. In contrast, there was no change in adipose tissue or heart LPL mRNA up to 24 h after treatment and no change in adipose tissue LPL synthetic rate, as measured by L-[35S]methionine incorporation and immunoprecipitation. Plasma insulin levels remained unchanged. The results indicate that endotoxin-induced hypertriglyceridemia in rats can be attributed to an impaired triglyceride clearance associated with a decrease of LPL activity mediated at a post-transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445338

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

1.  Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.

Authors:  Min Sun Kim; Trevor R Sweeney; Judy K Shigenaga; Lisa G Chui; Arthur Moser; Carl Grunfeld; Kenneth R Feingold
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

2.  Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.

Authors:  Melissa J Puppa; James P White; Shuichi Sato; Mark Cairns; John W Baynes; James A Carson
Journal:  Biochim Biophys Acta       Date:  2011-09-02

3.  Comparative studies of vertebrate lipoprotein lipase: a key enzyme of very low density lipoprotein metabolism.

Authors:  Roger S Holmes; John L Vandeberg; Laura A Cox
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2011-04-22       Impact factor: 2.674

4.  Lipid profile in HIV/AIDS patients in Nigeria.

Authors:  O O Adewole; S Eze; Ye Betiku; E Anteyi; I Wada; Z Ajuwon; G Erhabor
Journal:  Afr Health Sci       Date:  2010-06       Impact factor: 0.927

5.  Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts.

Authors:  R Carroll; L Liu; D L Severson
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

6.  Dyslipidaemia in a boy with recurrent abdominal pain, hypersalivation and decreased lipoprotein lipase activity.

Authors:  D Matern; H Seydewitz; H Niederhoff; H Wiebusch; M Brandis
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

7.  Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge.

Authors:  Frédéric Picard; Denis Arsenijevic; Denis Richard; Yves Deshaies
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

8.  A Study to Evaluate Lipid Profile in Treatment Naïve HIV Positive Patients.

Authors:  Anitha Devanath; Somdattaa Ray; Ravi Kumar; B S Prarthana
Journal:  Indian J Clin Biochem       Date:  2013-01-20

9.  Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice.

Authors:  Konstantinos Drosatos; Raffay S Khan; Chad M Trent; Hongfeng Jiang; Ni-Huiping Son; William S Blaner; Shunichi Homma; P Christian Schulze; Ira J Goldberg
Journal:  Circ Heart Fail       Date:  2013-04-09       Impact factor: 8.790

10.  Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor.

Authors:  H Nagasaka; H Kikuta; H Chiba; T Murano; H Harashima; A Ohtake; H Senzaki; N Sasaki; I Inoue; S Katayama; K Shirai; K Kobayashi
Journal:  Eur J Pediatr       Date:  2003-01-23       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.